InsidersTradesSigma
Track the IMPEL PHARMACEUTICALS INC stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). The latest transaction was disclosed on 19 December 2023 (Cession). Among the most active insiders: Vivo Capital VIII, LLC. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IMPEL PHARMACEUTICALS INC es una empresa centrada en el desarrollo de tratamientos innovadores para enfermedades neurológicas. Su objetivo es proporcionar soluciones terapéuticas que mejoren la calidad de vida de los pacientes.